The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of PSMA PET/CT derived predictive markers for 177Lu-PSMA-617 treatment outcomes: Results from the U.S. Expanded-Access program.
 
Koichiro Kimura
No Relationships to Disclose
 
Vishnu Murthy
No Relationships to Disclose
 
Andrew Voter
No Relationships to Disclose
 
Abuzar Moradi Tuchayi
No Relationships to Disclose
 
Surekha Yadav
No Relationships to Disclose
 
Lilja Solnes
Consulting or Advisory Role - Novartis
Research Funding - Advanced Accelerator Applications/Novartis; Progenics
 
Lela Theus
Employment - UCLA Health
 
Andrew Nguyen
Employment - UCLA Health
 
Vinicius Ludwig
No Relationships to Disclose
 
Adrien Holzgreve
Consulting or Advisory Role - ABX Advanced biochemical compounds
Research Funding - ABX Advanced biochemical compounds (Inst)
 
Lena Unterrainer
No Relationships to Disclose
 
Tristan Grogan
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Aktis Oncology; RayzeBio
 
Thomas Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - Cardinal Health; GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Bayer (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst); Philips Healthcare (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Andrei Gafita
No Relationships to Disclose
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics